Episode Details

Anthropic and OpenEvidence are expanding clinical AI decision support across roughly 100 countries, while a packed model-release cycle sharpens the economics of frontier AI. We also examine a new serving-engineering benchmark that exposes the difference between patches that pass local tests and ones that work in production.

Covered in this episode:
- Anthropic and OpenEvidence partner on free clinical decision support for providers in dozens of low- and middle-income countries.
- Claude Opus 5.5 and OpenAI’s GPT-6 Sol and Luna arrive amid lower model prices.
- Flash-dLLM proposes faster, more memory-efficient inference for diffusion language models.
- SWE-Serve tests whether coding agents can complete production inference-engineering work.
- Qualcomm’s new phone chips and local model execution.
- Ande’s funding for AI-powered corporate-event booking.
- Parallel’s reported GPT-6 Astra research-workflow results.

Source links:
- Reuters on Anthropic and OpenEvidence: https://www.reuters.com/legal/litigation/anthropic-openevidence-partner-bring-medical-ai-worldwide-2026-09-22
- Simon Willison on Claude Opus 5.5 and GPT-6 pricing: https://simonwillison.net/2026/Sep/22/opus-and-sol-and-luna/
- Flash-dLLM paper: https://arxiv.org/abs/2609.26796v1
- SWE-Serve paper: https://arxiv.org/abs/2609.26777v1
- TechCrunch on Qualcomm’s chips: https://techcrunch.com/2026/09/22/qualcomm-launches-two-new-smartphone-chips-with-emphasis-on-ai/
- The Information on Ande: https://www.theinformation.com/articles/entertainment-booking-startup-ande-raises-52-million-lightspeed-redpoint
- OpenAI on Parallel and GPT-6 Astra: https://openai.com/index/parallel-cuts-time-and-cost-with-astra